EU withdraws marketing authorisation for Abbvie's hepatitis C drugThe regulator said it withdrew authorisation for the drug on September 25.
Last Updated IST
AbbVie logo.
Credit: AbbVie.com
The European Medicines Agency said on Tuesday that it has withdrawn the marketing authorisation for Abbvie's hepatitis C drug Exviera at the request of the company.
The regulator said it withdrew authorisation for the drug on September 25.